- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.08. | L A M Y: Exousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment | 313 | ACCESS Newswire | Strategic Financing to Accelerate Exosome Pipeline Expansion, International Joint Ventures, and Scale-Up of NexTel Medical (MAJI) ORLANDO, FL / ACCESS Newswire / August 4, 2026 / Exousia Bio, Inc. f/k/a... ► Artikel lesen | |
| 22.07. | Exousia Pro, Inc.: NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform | 176 | GlobeNewswire (Europe) | Revised transaction expands NexTel's acquisition from JumpstartRx and NuevistraMed to Island 40 Group's broader growth platform, adding health services, pharmaceutical access, lab testing, institutional... ► Artikel lesen | |
| 16.06. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 09.06. | Exousia Pro, Inc.: NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University | 782 | GlobeNewswire (Europe) | Led by Scientific Advisory Board Members Dr. John Bitzer and Dr. Marvin Hausman, the Study Utilizes Advanced Mass Spectrometry to Identify the Precise Bioactive Healing Compounds Within Proprietary... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 02.06. | Exousia Pro, Inc.: NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome Commercialization | 296 | GlobeNewswire (Europe) | Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026... ► Artikel lesen | |
| 11.05. | Exousia Pro, Inc.: NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist | 284 | GlobeNewswire (Europe) | ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery... ► Artikel lesen | |
| 14.04. | Exousia Bio, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 07.04. | Exousia Pro, Inc.: NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test | 1 | GlobeNewswire (USA) | ||
| 17.03. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 16.03. | Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value | 545 | GlobeNewswire (Europe) | ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 05.03. | Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions | 175 | GlobeNewswire (Europe) | ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce... ► Artikel lesen | |
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 510 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 475 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 541 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 400 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 554 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 699 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 525 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 565 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 555 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 253,50 | +1,24 % | Sartorius Vz.: Reicht ein neues Kursziel, um die Kurve zu kriegen? | Die Schweizer Großbank UBS hob das Kursziel für die Sartorius Vorzugsaktie am Donnerstag deutlich von 240 auf 300 Euro an, die Aktie reagierte umgehend positiv. Aber kann so etwas ausreichen, um die... ► Artikel lesen | |
| UNUSUAL MACHINES | 23,955 | +0,02 % | Nächstes KI-Highlight?: Anthropic vor Mega-IPO: Toppt Claude im Oktober sogar SpaceX? | © Foto: KI-generiert mit DALL-E KI gegen Space: Wer hat die Nase vorn? Anthropic könnte im Oktober an die Börse gehen - mit einer Bewertung von mehr als 2 Billionen US-Dollar. Der Claude-Entwickler... ► Artikel lesen | |
| LIGHTWAVE LOGIC | 5,490 | 0,00 % | Lightwave Logic, Inc. Announces Timing of Second Quarter 2026 Financial Results and Business Update Call | ENGLEWOOD, CO / ACCESS Newswire / August 3, 2026 / Lightwave Logic, Inc. (NASDAQ:LWLG) (the "Company"), a technology platform company leveraging its proprietary electro-optic (EO) polymers to enable... ► Artikel lesen | |
| DRONESHIELD | 1,085 | -0,05 % | DroneShield, Rheinmetall und Focus Graphite: Warum Trumps neue Drohnen-Offensive jetzt bis zu den Rohstoffen reicht | ||
| SONOVA | 250,40 | +0,36 % | Sonova Holding AG: Sonova stärkt Innovationsführerschaft mit Phonak EON Portfolio und proprietärer Echtzeit-KI der dritten Generation | Sonova Holding AG
/ Schlagwort(e): Produkteinführung
Sonova stärkt Innovationsführerschaft mit Phonak EON Portfolio und proprietärer Echtzeit-KI der dritten Generation 24.08.2026... ► Artikel lesen | |
| SERVE ROBOTICS | 5,025 | -0,10 % | Why Is Serve Robotics Stock Falling, and is it a Buying Opportunity? | ||
| PVA TEPLA | 30,860 | +2,66 % | EQS-PVR: PVA TePla AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: PVA TePla AG
PVA TePla AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| ITURAN LOCATION AND CONTROL | 50,78 | 0,00 % | Ituran überrascht mit starkem Q2 - versteckte Wachstumsstory im eigenen Telematik-Netzwerk | Ituran liefert ein starkes zweites Quartal ab und öffnet zugleich den Blick auf eine unterschätzte Asset-Basis: das eigene Telematik-Netzwerk. Für Investoren entsteht damit ein klareres Bild des Ertragspotenzials... ► Artikel lesen | |
| 2G ENERGY | 55,40 | -0,09 % | 2G Energy: Besser als Aixtron und SUSS | Die Aktien der deutschen Unternehmen, die von der KI-Investitionswelle stark profitieren, sind nach einer massiven Rally weiter im Konsolidierungsmodus. Top-Performer wie Aixtron oder SUSS MicroTec... ► Artikel lesen | |
| GPGI | 13,270 | 0,00 % | GPGI, Inc.: Husky Technologies Appoints Mohammad Kanaan as Chief Financial Officer and Karen Stone as Chief Human Resources Officer | BOLTON, Ontario, May 28, 2026 (GLOBE NEWSWIRE) -- GPGI, Inc. (NYSE: GPGI) today announced the appointments of Mohammad Kanaan as Chief Financial Officer and Karen Stone as Chief Human Resources Officer... ► Artikel lesen | |
| EVOLV TECHNOLOGIES | 5,250 | +0,19 % | Evolv Technology reports customer growth, product adoption | ||
| AIRJOULE TECHNOLOGIES | 4,555 | -0,11 % | AirJoule Technologies Corporation: AirJoule Technologies Announces Second Quarter 2026 Results and Provides Business Update | RONAN, Mont., Aug. 13, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) ("AirJoule Technologies" or "AIRJ"), a leading platform technology that unleashes the power of water... ► Artikel lesen | |
| WRAP TECHNOLOGIES | 1,610 | 0,00 % | Wrap Technologies Inc. (NASDAQ: WRAP) Executes Deliberate Strategy to Establish Position in Vital Defense Sector | ||
| HUDSON TECHNOLOGIES | 5,430 | 0,00 % | Hudson Technologies Reports First Quarter 2026 Results | First Quarter 2026 Financial Highlights Revenue increased 9% to $60.2 million 20% sales volume growthShare repurchases of $2.5 millionHFC prices firming above $6 per pound WOODCLIFF LAKE, N.J., May... ► Artikel lesen | |
| RCM TECHNOLOGIES | 41,710 | 0,00 % | Kevin D Miller Takes Money Off The Table, Sells $129K In RCM Technologies Stock |
EXOUSIA ADVANCED MATERIALS INC gehört der Branche Sonstige Technologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.